Estimation of cell response in fractionation radiotherapy using different methods derived from linear quadratic model
References
- 1. Baskar R, Lee KA, Yeoh KW. Cancer and radiation therapy: current advances and future directions.2012;193-9.
- 2. Begg CA, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs.2011;239-53.
- 3. Stavrev P, Hristov D. Prostate IMRT fractionation strategies: two-phase treatment versus simultaneous integrated boost.2003;115-26.
- 4. Chang SX, Cullip TJ, Deschesne KM. Intensity modulation delivery techniques: ‘step & shoot’ MLC auto-sequence versus the use of a modulator.2000;948-59.
- 5. Verhey LJ. Physical considerations in the use of intensity modulated radiotherapy to produce three-dimensional conformal dose distributions.2000;191-203.
- 6. Jeraj M, Robar V. Multileaf collimator in radiotherapy.2004;235-40.
- 7. Ling CC, Burman C, Chui CS, Kutcher GJ, Leibel SA, LoSasso T, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.1996;721-30.
- 8. Mu X, Löfroth P-O, Karlsson M, Zackrisson B. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem.2003;181-7.
- 9. Keall PJ, Chang M, Benedict S, Thames H, Vedam SS, Lin P-S. Investigating the temporal effects of respiratory-gated and intensity-modulated radiotherapy treatment delivery on in vitro survival: an experimental and theoretical study.2008;1547-52.
- 10. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery.2004;242-9.
- 11. Zheng XK, Chen LH, Wang WJ, Ye F, Liu JB, Li QS, et al. Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing.2010,1541-7.
- 12. Paganetti H. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.2005;892-900.
- 13. Wang X, Xiong XP, Lu J, Zhu GP, He SQ, Hu CS, et al. The in vivo study on the radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with Lewis lung cancer.2011;4
- 14. Wang JZ, Li XA, D’souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).2003;543-52.
- 15. Shibamoto Y, Masato I, Sugie C, Ogino H, Hara M. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.2004;1484-90.
- 16. Ling CC, Gerweck LE, Zaider M, Yorke E. Dose-rate effects in external beam radiotherapy redux.2010;261-8.
- 17. Thames HD. An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations.1985;319-39.
- 18. Nilsson P, Thames HD, Joiner MC. A generalized formulation of the ‘incomplete repair’ model for cell survival and tissue response to fractionated low dose-rate irradiation.1990;127-42.
- 19. Rourke SFCO, Mcaneney H, Hillen T. Linear quadratic and tumor control probability modeling in external beam radiotherapy.2009;799-817.
- 20. Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.2008;234-9.
- 21. Jones L, Hoban P, Metcalfe H. The use of the linear quadratic model in radiotherapy: a review.2001;132-46.
- 22. Price P, McMillan TJ. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation.1990;1392-6.
- 23. Buch K, Peters T, Nawroth T, Sanger M, Schmidberger H, Langguth P. Determination of cell survival after irradiation via clonogenic assay versus multiple MTT assay – a comparative study.2012;1
- 24. Sieuwerts AM, Klijn JGM, Peters HA, Foekens JA. The MTT Tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival.1995;813-23.
- 25. Nikzad S, Hashemi B, Hasan Z S, Mozdarani H. The cell survival of F10B16 melanoma and 4T1 breast adenocarcinoma irradiated to gamma radiation using the MTT assay based on two different calculation methods.2013;29-36.
- 26. Nikzad S, Hashemi B. MTT assay instead of the clonogenic assay in measuring the response of cells to ionizing radiation.2014;3-8.
- 27. Shanei A, Baradaran-Ghahfarokhi M. Evaluation of testicular dose and associated risk from common pelvis radiation therapy in Iran.2014;867-70.
- 28. Cherubini R, De Nadal V, Gerardi S, Guryev D. Status report of a systematic investigation on low dose ionizing radiation effects in mammalian cells.2008;57-67.
- 29. Smith LG, Miller RC, Richard SM, Brenner DJ, Hall EJ, Phil D. Investigation of hypersensitivity to fractionated low dose radiation exposure.1999;187-91.
- 30. Marples B, Joiner MC. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population.1993;41-51.
- 31. Ling CC, Gerweck LE, Zaider M, Yorke E. Dose-rate effects in external beam radiotherapy redux.2010;261-8.
- 32. Ling CC, Spiro IJ, Mitchell J, Stickler R. The variation of OER with dose rate.1985;1367-73.
- 33. Michaels HB, Epp ER, Ling CC, Peterson EC. Oxygen sensitization of CHO cells at ultrahigh dose rates: prelude to oxygen diffusion studies.1978;510-21.
Language: English
Page range: 347 - 356
Submitted on: May 5, 2015
Accepted on: Aug 12, 2015
Published on: Nov 27, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2015 Safoora Nikzad, Bijan Hashemi, Golshan Mahmoudi, Milad Baradaran-Ghahfarokhi, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.